Shyr ZA, Yan Z, Ustione A, Egan EM, et al. SGLT2 inhibitors therapy protects glucotoxicity-induced beta-cell failure in a mouse model of human KATP-induced diabetes through mitigation of oxidative and ER stress. PLoS One 2022;17:e0258054.
PMID: 35180212